1mg, best e pharmacy in India
Rs.89.50for 1 strip(s) (10 tablets each)
1
Unfortunately, we don't have any more items in stock
Report Error

Composition FOR FULNITE

Eszopiclone(2 mg)

food interaction for FULNITE

alcohol interaction for FULNITE

pregnancy interaction for FULNITE

lactation interaction for FULNITE

medicine interaction for FULNITE

food
alcohol
pregnancy
lactation
medicine
It is better to take Fulnite 2 mg tablet empty stomach (1 hour before food or 2 hours after food).
Fulnite 2 mg tablet may cause excessive drowsiness and calmness with alcohol.
UNSAFE
Fulnite 2 mg tablet may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
WEIGH RISKS VS. BENEFITS
Unknown. Human and animal studies are not available. Please consult your doctor.
  • SERIOUS INTERACTION
    ONABET POWDER, CANDITRAL 100 MG CAPSULE, SYNTRAN 100 MG CAPSULE & 7 more
  • SALT INFORMATION FOR FULNITE

    Eszopiclone(2 mg)

    Uses

    Fulnite 2 mg tablet is used for insomnia (difficulty in sleeping)

    How it works

    Fulnite 2 mg tablet induces sleep by suppressing the excessive activity of the nerve cells in the brain.

    Common side effects

    Rash, Headache, Dizziness, Sleepiness, Dry mouth, Anxiety, Hallucination, Respiratory tract infection, Bitter taste, Viral infection

    SUBSTITUTES FOR FULNITE

    No substitutes found

    Top Physicians

    Expert advice FOR FULNITE

    • Do not drive or operate machinery immediately after or even on the day after taking eszopiclone (especially for dose of 3 mg) as it may cause drowsiness, dizziness, or blurred vision.
    • Tell your doctor if you have or have had a history of depression or other mental or mood disorders, or if you have a history of suicidal thoughts or behaviour, substance/alcohol dependence, severe lung or liver disease.
    • Seek immediate medical attention if you observe swelling (angioedema) involving the tongue, glottis or larynx or dyspnea, throat closing, or nausea and vomiting.
    • Consult your doctor immediately if you or your family notice any changes in your behavior (e.g., aggression, confusion etc), or if you have any unusual or disturbing thoughts or you are sleep-driving.
    • Do not stop taking eszopiclone suddenly as it may cause withdrawal symptoms. Your doctor will taper your dose before stopping it completely.
    • Take eszopiclone for short period of time (up to 2 weeks) to avoid developing tolerance (medicine losing effectiveness to help you sleep). When used for longer duration or at high doses there is a risk of developing dependence/addiction. 
    • Talk to your doctor if you are pregnant or planning to become pregnant or are breastfeeding.

    Frequently asked questions FOR FULNITE

    Eszopiclone

    Q.

    Is eszopiclone a narcotic/ benzodiazepine/ addictive?
    No, eszopiclone is not a narcotic or benzodiazepine. It belongs to a class of drugs called hypnotics (cyclopyrrolone). When used for longer duration or at high doses there is a risk of developing dependence/addiction

    Q.

    Is eszopiclone the same as lunesta/ zopiclone/generic?
    Yes, eszopiclone is a generic and available under the name of lunesta. It is not same as zopiclone

    Q.

    Can I take eszopiclone/ lunesta with hydrocodone/ ambien/ xanax/ oxycodone/ percocet/ ativan/ vicodin/ trazodone/ benadryl?
    You must consult your doctor before taking any other medications along with eszopiclone/ lunesta including but not limited to hydrocodone/ ambient/ xanax/ oxycodone/ percocet/ ativan/ vicodin/ trazodone/ Benadryl as they may interact with eszopiclone/ lunesta

    Show More
    Q.

    How does eszopiclone work?
    Eszopiclone belongs to a class of drugs called hypnotics (cyclopyrrolone). The exact mechanism of action is not known but its effect is believed to result from the increase of certain natural chemicals in the brain that induce sleep.

    Articles


    Content on this page was last updated on 03 February, 2017, by Dr. Varun Gupta (MD Pharmacology)